Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Teleflex Incorporated has announced its agreement to acquire most of the Vascular Intervention business from BIOTRONIK SE & Co. KG for approximately €760 million, pending regulatory approvals and ...

SACRAMENTO, Calif.--(BUSINESS WIRE)--Cutter Law PC announces that the international medical device company, Biotronik, Inc., has agreed to pay more than $12.95 million to the United States and various ...

LAKE OSWEGO, Ore., June 23, 2023 /PRNewswire/ -- Continuing a history of commitment to furthering research in its field, four studies supported by BIOTRONIK's real-world evidence generating research ...

Biotronik, a leader in cardio- and endovascular medical technology, announced a partnership with Maquet Medical Systems USA to distribute Biotronik peripheral vascular devices in the US. Biotronik and ...

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, Inc., announced that effective May 14, 2010, Patrick L. Horan has accepted the position of Vice President of Corporate Sales for U.S. Operations. Mr.

Health technology company Royal Philips partnered with Lake Oswego, Ore.-based Biotronik, a medical device business, to “expand care for out-of-hospital cardiology labs,” they said June 21. The ...

WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire ...

WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition ...